{"entity":{"id":"nct07300943","kind":"trial","name":"Study in Advanced Solid Tumor Patients","aka":[],"tldr":"A phase 1/2 trial of CLIO-8221 in advanced solid tumours, run by Callio Therapeutics, now recruiting.","summary":"Study in Advanced Solid Tumor Patients is a phase 1/2 interventional study registered as NCT07300943 by Callio Therapeutics, with 306 participants planned, started 2026-03-19 and due to reach its primary completion in 2027-12-31. Interventions recorded: CLIO-8221.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07300943","url":"https://clinicaltrials.gov/study/NCT07300943"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["callio-therapeutics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07300943","phase":"1/2","setting":"A Phase 1/2 Study of CLIO-8221 in Patients With Advanced Solid Tumors","sponsor":"Callio Therapeutics","enrolled":306,"outcomes":[]},"route":"/trials/nct07300943/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"company":[{"id":"callio-therapeutics","kind":"company","name":"Callio Therapeutics","route":"/companies/callio-therapeutics/"}]}}